All In MedTech

Device Trial Radar · NCT01362725

Spinal Cord Stimulation For Heart Failure

Spinal Cord Stimulation For Heart Failure As A Restorative Treatment

Last checked: Nov 20, 2026Latest source record: Feb 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

Apr 2011

Primary completion

Aug 2014

Study completion Jan 2016

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
May 30, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 95 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objectives of this feasibility study are to determine the safety of spinal cord stimulation (SCS) as a therapy in patients with systolic heart failure and to gather observational information for potential efficacy markers

Conditions

  • Systolic Heart Failure

Interventions

  • Spinal cord stimulation systemDevice

    An implantable pulse generator (IPG) will deliver low-intensity electrical pulses which travel from the IPG through the leads to the electrodes positioned at the selected nerve fibers to provide the therapeutic stimulation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and efficacy markersTime frame: 6 months

Locations

5 sites in 3 countries. Site status is shown where the registry gives one.

  • John Hunter Hospital

    New Lambton Heights, New South Wales, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Queen Mary Hospital

    Hong Kong, Hong Kong

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.